Sale!

CACNA1C Gene Brugada Syndrome Type 3 Genetic Test

Original price was: 5,600 د.إ.Current price is: 4,400 د.إ.

-21%

The “CACNA1C Gene Brugada Syndrome Type 3 Genetic Test” is a specific diagnostic tool used to identify mutations in the CACNA1C gene, which are associated with Brugada Syndrome Type 3. This condition is a rare inherited cardiac disorder that can lead to arrhythmias, fainting, and sudden cardiac death, particularly in young, healthy adults. The test is crucial for individuals with a family history of Brugada Syndrome or unexplained cardiac events, as it can help in making informed decisions regarding management and preventive measures for at-risk individuals.

Conducted at DNA Labs UAE, the test involves collecting a DNA sample, typically through a blood draw or cheek swab, which is then analyzed for specific genetic mutations in the CACNA1C gene. This gene plays a vital role in the electrical activity of the heart, and mutations can disrupt normal heart rhythm, leading to the symptoms associated with Brugada Syndrome.

The cost of the test is 4400 AED, reflecting the specialized nature of the genetic analysis and the comprehensive insights it provides into an individual’s risk of developing Brugada Syndrome Type 3. By identifying genetic predispositions, patients and healthcare providers can work together to monitor heart health closely and implement preventive strategies to mitigate the risk of serious cardiac events.

Home  Sample collection service available

  • 100% accuaret Test Results
  • Ranked as Most trusted Genetic DNA Lab
  • This test is not intended for medical diagnosis or treatment
Guaranteed Safe Checkout

CACNA1C Gene Brugada Syndrome Type 3 Genetic Test

Test Name: CACNA1C Gene Brugada syndrome type 3 Genetic Test

Components: Blood or Extracted DNA or One drop Blood on FTA Card

Price: 4400.0 AED

Report Delivery: 3 to 4 Weeks

Method: NGS Technology

Test Type: Cardiovascular Pneumology Disorders

Doctor: Cardiologist

Test Department: Genetics

Pre Test Information: Clinical History of Patient who is going for CACNA1C Gene Brugada syndrome type 3 NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with CACNA1C Gene Brugada syndrome type 3 NGS Genetic DNA Test gene CACNA1C

Test Details

The CACNA1C gene is associated with Brugada syndrome type 3. Brugada syndrome is a rare genetic disorder that affects the electrical system of the heart, leading to abnormal heart rhythms and potentially life-threatening arrhythmias.

NGS (Next Generation Sequencing) Genetic Test is a type of genetic testing that uses advanced sequencing technologies to analyze multiple genes simultaneously. It allows for the detection of genetic mutations or variations in multiple genes, including the CACNA1C gene, associated with Brugada syndrome type 3.

By analyzing the DNA sequence of the CACNA1C gene, the NGS Genetic Test can identify any genetic mutations or variations that may be present and help in diagnosing Brugada syndrome type 3. This information can then be used to guide treatment decisions and management of the condition.

Test Name CACNA1C Gene Brugada syndrome type 3 Genetic Test
Components
Price 4400.0 AED
Sample Condition Blood or Extracted DNA or One drop Blood on FTA Card
Report Delivery 3 to 4 Weeks
Method NGS Technology
Test type Cardiovascular Pneumology Disorders
Doctor Cardiologist
Test Department: Genetics
Pre Test Information Clinical History of Patient who is going for CACNA1C Gene Brugada syndrome type 3 NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with CACNA1C Gene Brugada syndrome type 3 NGS Genetic DNA Test gene CACNA1C
Test Details

CACNA1C gene is associated with Brugada syndrome type 3. Brugada syndrome is a rare genetic disorder that affects the electrical system of the heart, leading to abnormal heart rhythms and potentially life-threatening arrhythmias.

NGS (Next Generation Sequencing) Genetic Test is a type of genetic testing that uses advanced sequencing technologies to analyze multiple genes simultaneously. It allows for the detection of genetic mutations or variations in multiple genes, including the CACNA1C gene, associated with Brugada syndrome type 3.

By analyzing the DNA sequence of the CACNA1C gene, the NGS Genetic Test can identify any genetic mutations or variations that may be present and help in diagnosing Brugada syndrome type 3. This information can then be used to guide treatment decisions and management of the condition.